predictors of early serologic diagnosis of aq4-igg positive nmosd
Published 1 year ago • 66 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
5:25
current diagnostic and treatment measures for aqp4-igg-positive nmosd
-
5:10
prevent study: eculizumab in aqp4-igg-positive nmosd
-
3:38
is aqp4-igg nmosd an exclusively relapsing disease?
-
1:32
new agents under investigation to treat aqp4-positive nmosd
-
21:35
aqp4-igg facs assay: finding nemo [hot topic]
-
5:44
diagnostic criteria and treatment updates for nmosd
-
3:18
identifying risk factors for aqp4 nmosd
-
3:38
prevent study: eculizumab in patients with aqp4 immunoglobin g-positive nmosd
-
2:21
nmosd: the importance of early diagnosis and treatment
-
2:07
prognostic factors in nmosd: age, ethnicity, and relapse history
-
1:21
novel treatment strategies for nmosd
-
10:36
spheres: collecting real-world data to explore disease characteristics & clinical outcomes in nmosd
-
4:49
comorbidities in ms and nmosd
-
0:47
the importance of treating nmosd early
-
5:22
tips for diagnosing neuromyelitis optica spectrum disorder
-
6:38
recent evidence for subclinical disease activity in nmosd
-
2:44
updates on n-momentum: inebilizumab versus placebo in patients with nmosd
-
8:46
neuromyelitis spectrum disorders
-
5:23
diagnosing pediatric neuromyelitis optica